NCT02751138View on ClinicalTrials.gov

Determination of Immune Phenotype in Glioblastoma Patients

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

December 1, 2022

Study Completion Date

January 1, 2023

Conditions
Glioblastoma Multiforme
Interventions
PROCEDURE

Surgery

Tumor resection

Trial Locations (1)

89081

Department of Neurosurgery, Ulm

All Listed Sponsors
lead

University of Ulm

OTHER

NCT02751138 - Determination of Immune Phenotype in Glioblastoma Patients | Biotech Hunter | Biotech Hunter